Multiple companies have scheduled U.S. IPOs for late September 2026, including Amaero, ADARx Pharmaceuticals, Oura, Accelevation Holdings, and Bamboo Insurance Services, with pricing ranges and underwriters already disclosed in recent SEC filings. Biotech and health-tech issuers dominate the near-term slate amid strong investor demand for growth names, while SPAC and smaller deals add further volume. Equity market conditions, including elevated trading multiples in tech and healthcare sectors plus available capital from institutional buyers, support execution of these offerings before year-end. No major regulatory or macroeconomic hurdles have emerged to delay the window, and additional filings continue to enter the pipeline.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedDiscord IPO probability collapses amid regulatory delays and market uncertainty
Discord plunges to 11%18%
Discord's expected IPO timeline shifted from early 2026 to mid-2027 due to SEC backlog and valuation concerns, causing market probabilities for a 2026 IPO to collapse and delaying its public debut.

































Beware of external links.
Beware of external links.
Frequently Asked Questions